REVIEW
|
doi:10.20944/preprints202304.0843.v2
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
CLL, Zanubrutinib, BTK inhibitors, efficacy, safety, chronic lymphocytic leukemia
Online: 22 May 2023 (16:15:16 CEST)
REVIEW
|
doi:10.20944/preprints202306.1898.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
chronic lymphocytic leukemia; older patient; ibrutinib; acalabrutinib; zanubrutinib; venetoclax; sustainabiity
Online: 27 June 2023 (12:04:57 CEST)
ARTICLE
|
doi:10.20944/preprints202306.1297.v1
Subject:
Medicine And Pharmacology,
Cardiac And Cardiovascular Systems
Keywords:
Heart failure; β-adrenergic receptor; cardiac fibrosis; cardiac inflammation; Bruton’s tyrosine kinase; Zanubrutinib
Online: 19 June 2023 (05:23:12 CEST)
REVIEW
|
doi:10.20944/preprints202112.0282.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Acalabrutinib; Bruton’s tyrosine kinase; BTK; CLL; Covalent inhibitors; COVID-19; Ibrutinib; Non-covalent inhibitors; Fenebrutinib; MK1026; Pirtobrutinib; Spebrutinib; Tirabrutinib; Zanubrutinib
Online: 16 December 2021 (16:13:54 CET)